目錄:MedChemExpress LLC>>生化試劑>> Selpercatinib | MCE
CAS | 2152628-33-4 | 純度 | 99.87% |
---|---|---|---|
分子量 | 525.6 | 分子式 | C??H??N?O? |
供貨周期 | 現(xiàn)貨 | 規(guī)格 | 5 mg |
貨號 | HY-114370 | 應用領(lǐng)域 | 醫(yī)療衛(wèi)生,化工,生物產(chǎn)業(yè),制藥/生物制藥 |
MCE 的所有產(chǎn)品僅用作科學研究或藥證申報,我們不為任何個人用途提供產(chǎn)品和服務。
CAS No. : 2152628-33-4
產(chǎn)品活性:Selpercatinib (LOXO-292) is a potent, selective RET kinase inhibitor with IC50 values of 14.0 nM, 24.1 nM, and 530.7 nM for RET (WT), RET (V804M), and RET (G810R), respectively. Selpercatinib has anticancer activity.
研究領(lǐng)域:Protein Tyrosine Kinase/RTK
作用靶點:RET
In Vivo: Selpercatinib (LOXO-292; 10 mg/kg; i.g.; for 0-2 h) has good pharmacokinetics after oral gavage in FVB/NRj mice.
Pharmacokinetic Parameters of Selpercatinib in FVB/NRj mice.
Administration | i.g. (10 mg/kg) |
Tmax (h) | 1.8 |
Cmax (ng/mL) | 7862 |
AUC (ng·h/mL) | 26649 |
FVB/NRj mice, 10 mg/kg i.g.
相關(guān)產(chǎn)品:Drug Repurposing Compound Library Plus | FDA-Approved Drug Library Plus | FDA-Approved Drug Library Mini | Bioactive Compound Library Plus | Kinase Inhibitor Library | Protein Tyrosine Kinase Compound Library | FDA-Approved Drug Library | Anti-Cancer Compound Library | Drug Repurposing Compound Library | Orally Active Compound Library | FDA Approved & Pharmacopeial Drug Library | Anti-Lung Cancer Compound Library | Anti-Pancreatic Cancer Compound Library | Targeted Therapy Drug Library | Targeted Diversity Library | Anti-Liver Cancer Compound Library | Rare Diseases Drug Library | FDA-Approved Anticancer Drug Library | Human Metabolite Library | Heterocyclic Compound Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | trans-Pralsetinib | BT-13 | RET-IN-16 | WF-47-JS03 | Pyrazoloadenine | GSK3179106 | RET-IN-1 | Lenvatinib-d5 | Pz-1 | Regorafenib monohydrate | RET-IN-14 | AD57 | AD80 | FLT3/ITD-IN-4 | RET-IN-18 | Regorafenib-13C,d3 | RET V804M-IN-1 | RET-IN-19 | Enbezotinib | RET-IN-6 | BT44 | TG101209 | Regorafenib-d3 | Amuvatinib | WHI-P180 | RET-IN-10 | Zeteletinib
熱門產(chǎn)品線:重組蛋白 | 化合物庫 | 天然產(chǎn)物 | 熒光染料 | PROTAC | 同位素標記物 | 寡核苷酸 | 抗體 | 點擊化學
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介紹:
• MCE (MedChemExpress) 擁有200 多種*僅有化合物庫,我們致力于為*科研客戶提供前沿的高品質(zhì)小分子活性化合物;
• 50,000 多種高選擇性抑制劑、激動劑涉及各熱門信號通路及疾病領(lǐng);
• 產(chǎn)品種類涵蓋各種重組蛋白,多肽,常用試劑盒 ,更有 PROTAC、ADC 等特色產(chǎn)品,廣泛應用于新藥研發(fā)、生命科學等科研項目;
• 提供虛擬篩選,離子通道篩選,代謝組學分析檢測分析,藥物篩選等專業(yè)技術(shù)服務;
• 設有專業(yè)的實驗中心和嚴格的質(zhì)控、驗證體系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項質(zhì)檢報告,確保產(chǎn)品的高純度、高品質(zhì);
• 產(chǎn)品的生物活性多經(jīng)各國客戶實驗驗證;
• Nature, Cell, Science 等多種頂級期刊及制藥 Patent 收錄了MCE客戶的科研成果;
• 專業(yè)團隊跟蹤新的制藥及生命科學研究進展,為您提供*新的活性化合物;
• 與世界各大制藥公司及*科研機構(gòu)建立了長期的合作。
| 巩义市| 上饶市| 嘉峪关市| 普兰店市| 望江县| 静安区| 迁西县| 拜城县| 洪江市| 当涂县| 克拉玛依市| 朔州市| 阳东县| 西盟| 济源市| 农安县| 汉寿县| 宝坻区| 林甸县| 广昌县| 武威市| 高邑县| 洛阳市| 永川市| 北海市| 雷波县| 清新县| 岳阳市| 电白县| 大丰市| 磐石市| 若羌县| 祁东县| 平和县| 托克逊县| 镇远县| 青岛市| 卢龙县| 县级市| 新余市|